• 2024
  Mitri C, Philippart F, Sacco E, Legriel S, Rousselet N, Dupuis G, Colsch B, Corvol H, Touqui L, Tabary O, Multicentric investigations of the role in the disease severity of accelerated phospholipid changes in COVID-19 patient airway., Microbes Infect 2024 May; (): 105354.
• 2022
  Wagner MP, Formaglio P, Gorgette O, Dziekan JM, Huon C, Berneburg I, Rahlfs S, Barale JC, Feinstein SI, Fisher AB, Ménard D, Bozdech Z, Amino R, Touqui L, Chitnis CE, , Human peroxiredoxin 6 is essential for malaria parasites and provides a host-based drug target., Cell Rep 2022 Jun; 39(11): 110923.
• 2017
  van der Vorst EP, Theodorou K, Wu Y, Hoeksema MA, Goossens P, Bursill CA, Aliyev T, Huitema LF, Tas SW, Wolfs IM, Kuijpers MJ, Gijbels MJ, Schalkwijk CG, Koonen DP, Abdollahi-Roodsaz S, McDaniels K, Wang CC, Leitges M, Lawrence T, Plat J, Van Eck M, Rye KA, Touqui L, de Winther MP, Biessen EA, Donners MM, High-Density Lipoproteins Exert Pro-inflammatory Effects on Macrophages via Passive Cholesterol Depletion and PKC-NF-κB/STAT1-IRF1 Signaling, Cell Metab. 2017 Jan;25(1):197-207.
• 2015
  Pernet E, Brunet J, Guillemot L, Chignard M, Touqui L, Wu Y, Staphylococcus aureus Adenosine Inhibits sPLA2-IIA-Mediated Host Killing in the Airways, J. Immunol. 2015 Jun;194(11):5312-9.
• 2015
  Martin C, Burgel PR, Lepage P, Andréjak C, de Blic J, Bourdin A, Brouard J, Chanez P, Dalphin JC, Deslée G, Deschildre A, Gosset P, Touqui L, Dusser D, Host-microbe interactions in distal airways: relevance to chronic airway diseases, Eur Respir Rev 2015 Mar;24(135):78-91.
• 2014
  Velard F, Delion M, Lemaire F, Tabary O, Guillaume C, Le Pimpec Barthès F, Touqui L, Gangloff S, Sermet-Gaudelus I, Jacquot J, Cystic fibrosis bone disease: is the CFTR corrector C18 an option for therapy?, Eur. Respir. J. 2015 Mar;45(3):845-8.
• 2014
  Pernet E, Guillemot L, Burgel PR, Martin C, Lambeau G, Sermet-Gaudelus I, Sands D, Leduc D, Morand PC, Jeammet L, Chignard M, Wu Y, Touqui L, Pseudomonas aeruginosa eradicates Staphylococcus aureus by manipulating the host immunity, Nat Commun 2014 Oct;5:5105.
• 2014
  Guillemot L, Medina M, Pernet E, Leduc D, Chignard M, Touqui L, Wu Y, Cytosolic phospholipase A2α enhances mouse mortality induced by Pseudomonas aeruginosa pulmonary infection via interleukin 6, Biochimie 2014 Dec;107 Pt A:95-104.
• 2014
  Velard F, Delion M, Le Henaff C, Guillaume C, Gangloff S, Jacquot J, Tabary O, Touqui L, Barthes F, Sermet-Gaudelus I, Cystic fibrosis and bone disease: defective osteoblast maturation with the F508del mutation in cystic fibrosis transmembrane conductance regulator, Am. J. Respir. Crit. Care Med. 2014 Mar;189(6):746-8.
• 2014
  Marteyn BS, Karimova G, Fenton AK, Gazi AD, West N, Touqui L, Prevost MC, Betton JM, Poyraz O, Ladant D, Gerdes K, Sansonetti PJ, Tang CM, ZapE is a novel cell division protein interacting with FtsZ and modulating the Z-ring dynamics, MBio 2014 Mar;5(2):e00022-14.
• 2014
  Benmohamed F, Medina M, Wu YZ, Maschalidi S, Jouvion G, Guillemot L, Chignard M, Manoury B, Touqui L, Toll-like receptor 9 deficiency protects mice against Pseudomonas aeruginosa lung infection, PLoS ONE 2014;9(3):e90466.
• 2013
  Movert E, Wu Y, Lambeau G, Kahn F, Touqui L, Areschoug T, Secreted group IIA phospholipase A2 protects humans against the group B streptococcus: experimental and clinical evidence, J. Infect. Dis. 2013 Dec;208(12):2025-35.
• 2013
  Martin C, Coolen N, Wu Y, Thévenot G, Touqui L, Prulière-Escabasse V, Papon JF, Coste A, Escudier E, Dusser DJ, Fajac I, Burgel PR, CFTR dysfunction induces vascular endothelial growth factor synthesis in airway epithelium, Eur. Respir. J. 2013 Dec;42(6):1553-62.
• 2012
  Ben Mohamed F, Mohamed FB, Garcia-Verdugo I, Medina M, Balloy V, Chignard M, Ramphal R, Touqui L, A crucial role of Flagellin in the induction of airway mucus production by Pseudomonas aeruginosa, PLoS ONE 2012;7(7):e39888.
• 2012
  Touqui L, Antisense inhibition of phospholipase A2: a new approach for already tested therapeutic targets for the treatment of sepsis*, Crit. Care Med. 2012 Jul;40(7):2250-1.
• 2012
  Garcia-Verdugo I, BenMohamed F, Tattermusch S, Leduc D, Charpigny G, Chignard M, Ollero M, Touqui L, A role for 12R-lipoxygenase in MUC5AC expression by respiratory epithelial cells, Eur. Respir. J. 2012 Sep;40(3):714-23.
• 2012
  Barbier D, Garcia-Verdugo I, Pothlichet J, Khazen R, Descamps D, Rousseau K, Thornton D, Si-Tahar M, Touqui L, Chignard M, Sallenave JM, Influenza A induces the major secreted airway mucin MUC5AC in a protease-EGFR-extracellular regulated kinase-Sp1-dependent pathway, Am. J. Respir. Cell Mol. Biol. 2012 Aug;47(2):149-57.
• 2011
  Movert E, Wu Y, Lambeau G, Touqui L, Areschoug T, A novel bacterial resistance mechanism against human group IIA-secreted phospholipase A2: role of Streptococcus pyogenes sortase A, J. Immunol. 2011 Dec;187(12):6437-46.
• 2010
  Wu YZ, Abolhassani M, Ollero M, Dif F, Uozumi N, Lagranderie M, Shimizu T, Chignard M, Touqui L, Cytosolic phospholipase A2alpha mediates Pseudomonas aeruginosa LPS-induced airway constriction of CFTR -/- mice, Respir. Res. 2010;11:49.
• 2003
  Touqui L, Wu YZ, Interaction of secreted phospholipase A2 and pulmonary surfactant and its pathophysiological relevance in acute respiratory distress syndrome, Acta Pharmacol. Sin. 2003 Dec;24(12):1292-6.
• 2003
  Attalah HL, Wu Y, Alaoui-El-Azher M, Thouron F, Koumanov K, Wolf C, Brochard L, Harf A, Delclaux C, Touqui L, Induction of type-IIA secretory phospholipase A2 in animal models of acute lung injury, Eur. Respir. J. 2003 Jun;21(6):1040-5.
• 2002
  Alaoui-El-Azher M, Wu Y, Havet N, Israël A, Lilienbaum A, Touqui L, Arachidonic acid differentially affects basal and lipopolysaccharide-induced sPLA(2)-IIA expression in alveolar macrophages through NF-kappaB and PPAR-gamma-dependent pathways, Mol. Pharmacol. 2002 Apr;61(4):786-94.
• 2002
  Wu Y, Singer M, Thouron F, Alaoui-El-Azher M, Touqui L, Effect of surfactant on pulmonary expression of type IIA PLA(2) in an animal model of acute lung injury, Am. J. Physiol. Lung Cell Mol. Physiol. 2002 Apr;282(4):L743-50.